Publications
View and download slide summaries of the latest original articles focusing on cytokine signalling therapies within rheumatoid arthritis. All materials produced by the CSF team are subsequently reviewed and approved by individual Steering Committee members.
February 2023
Eficacia y Seguridad de Bimekizumab en las Espondiloartritis Axiales: Resultados de Dos Ensayos Paralelos de Fase 3 Aleatorizados y Controlados
Ann Rheum Dis. 2023 Jan 17 doi: 10.1136/ard-2022-223595
Bimekizumab may therefore offer patients with axSpA an effective treatment option with a novel mode of action.